Bill Text: FL S0398 | 2019 | Regular Session | Introduced

Florida Senate Bill 398 (Prior Session Legislation)

Introduced

Bill Title: Prior Authorization for Opioid Alternatives

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Failed) 2019-05-03 - Died in Banking and Insurance [S0398 Detail]

Download: Florida-2019-S0398-Introduced.html

       Florida Senate - 2019                                     SB 398
       
       
        
       By Senator Farmer
       
       
       
       
       
       34-00707-19                                            2019398__
    1                        A bill to be entitled                      
    2         An act relating to prior authorization for opioid
    3         alternatives; amending s. 627.64195, F.S.; prohibiting
    4         health insurance policies from requiring that
    5         treatment with an opioid analgesic drug product be
    6         attempted and have failed before authorizing the use
    7         of a nonopioid-based analgesic drug product; providing
    8         an effective date.
    9          
   10  Be It Enacted by the Legislature of the State of Florida:
   11  
   12         Section 1. Subsection (2) of section 627.64195, Florida
   13  Statutes, is amended to read:
   14         627.64195 Requirements for opioid coverage.—
   15         (2) COVERAGE REQUIREMENTS.—
   16         (a) A health insurance policy may not require that
   17  treatment with an opioid analgesic drug product be attempted and
   18  have failed before authorizing the use of a nonopioid-based
   19  analgesic drug product.
   20         (b) A health insurance policy that provides coverage for
   21  abuse-deterrent opioid analgesic drug products:
   22         1.(a) May impose a prior authorization requirement for an
   23  abuse-deterrent opioid analgesic drug product only if the policy
   24  imposes the same prior authorization requirement for each opioid
   25  analgesic drug product without an abuse-deterrence labeling
   26  claim.
   27         2.(b) May not require use of an opioid analgesic drug
   28  product without an abuse-deterrence labeling claim before
   29  authorizing the use of an abuse-deterrent opioid analgesic drug
   30  product.
   31         Section 2. This act shall take effect July 1, 2019.